Product Information
EQUETRO 100 MG CAPSULE is a brand product labeled by Validus Pharmaceuticals LLC, priced at $3.6529 per EA under NDC 30698041912. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on Dec 10, 2004.
The High Outlier badge above means this manufacturer's average price in the Carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Validus Pharmaceuticals LLCNDC
30698041912
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBAMAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA021710FDA Approved
12/10/2004
On Market Since
12/10/2004
Pharmacological Classes
Price Statistics
The NADAC for EQUETRO 100 MG CAPSULE has been published 114 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6529 per EA |
|---|---|
| All-time high | $3.7141 (Oct 16, 2024) |
| All-time low | $3.6513 (Jul 22, 2026) |
| 52-week high | $3.6935 |
| 52-week low | $3.6513 |
| Median price | $3.6935 |
| Average price | $3.6894 |
| Largest weekly change | -0.5% (Oct 23, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EQUETRO 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EQUETRO 100 MG CAPSULE, manufactured by Validus Pharmaceuticals LLC, is $3.6529 per EA (NDC 30698041912), effective Aug 19, 2026.
How has the price of EQUETRO 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EQUETRO 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for EQUETRO 100 MG CAPSULE?
Since Jun 19, 2024, the NADAC for EQUETRO 100 MG CAPSULE has ranged from a low of $3.6513 (Jul 22, 2026) to a high of $3.7141 (Oct 16, 2024), with a median of $3.6935 per EA.
Are there cheaper alternatives to EQUETRO 100 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE ER 100 MG CAP, is $1.1073 per EA — about 70% below EQUETRO 100 MG CAPSULE.
Who manufactures EQUETRO 100 MG CAPSULE?
EQUETRO 100 MG CAPSULE (NDC 30698041912) is labeled by Validus Pharmaceuticals LLC, and CMS classifies it as a brand product.